Accelerating Solid Tumour Cell Therapy Development Through Adaptive Trial Design & Regulatory Strategy
1:45 pm - Tuesday 9th February 2027
- Optimising eligibility criteria and patient selection strategies to enhance clinical outcomes and accelerate development in solid tumours
- Leveraging adaptive trial designs and proactive regulatory engagement to streamline development pathways and support faster approvals
- Showcasing Phase II clinical data and key learnings to refine development strategies and advance next-generation solid tumour cell therapies
